🔗 Share this article

The top legal official in Texas Paxton is taking legal action against the makers of acetaminophen, asserting the firms withheld alleged dangers that the pain reliever created to pediatric neurological development.

The court filing comes a month after Donald Trump advocated an unproven link between taking acetaminophen - referred to as paracetamol - while pregnant and autism in young ones.

The attorney general is filing suit against Johnson & Johnson, which once produced the drug, the exclusive pain medication approved for pregnant women, and the current manufacturer, which presently makes it.

In a official comment, he claimed they "deceived the public by profiting off of pain and pushing pills ignoring the risks."

Kenvue states there is insufficient reliable data tying acetaminophen to autism.

"These manufacturers misled for generations, knowingly endangering numerous people to increase profits," Paxton, a Republican, said.

The company said in a statement that it was "very worried by the dissemination of inaccurate information on the reliability of paracetamol and the likely effects that could have on the well-being of women and children in America."

On its official site, Kenvue also mentioned it had "consistently assessed the applicable studies and there is lacking reliable evidence that indicates a verified association between using acetaminophen and autism."

Organizations representing physicians and medical practitioners concur.

The leading OB-GYN organization has said paracetamol - the main ingredient in Tylenol - is a restricted selection for pregnant women to address pain and elevated temperature, which can create serious health risks if ignored.

"In multiple decades of investigation on the utilization of paracetamol in pregnancy, not a single reputable study has conclusively proven that the usage of acetaminophen in any period of gestation leads to neurodevelopmental disorders in young ones," the group stated.

The lawsuit references latest statements from the former administration in arguing the drug is allegedly unsafe.

In recent weeks, the former president caused concern from medical authorities when he instructed women during pregnancy to "struggle intensely" not to consume Tylenol when ill.

The US Food and Drug Administration then released a statement that doctors should think about restricting the usage of acetaminophen, while also declaring that "a causal relationship" between the drug and autism spectrum disorder in children has not been proven.

Health Secretary Kennedy, who manages the FDA, had pledged in April to initiate "a massive testing and research effort" that would establish the origin of autism spectrum disorder in a matter of months.

But experts cautioned that finding a sole reason of autism spectrum disorder - considered by experts to be the consequence of a intricate combination of genetic and environmental factors - would prove challenging.

Autism spectrum disorder is a form of lifelong neurodivergence and disability that influences how persons experience and engage with the world, and is diagnosed using doctors' observations.

In his lawsuit, the attorney general - aligned with the former president who is seeking US Senate - claims Kenvue and J&J "deliberately disregarded and sought to suppress the science" around acetaminophen and autism.

The lawsuit aims to force the corporations "destroy any marketing or advertising" that asserts Tylenol is reliable for pregnant women.

The Texas lawsuit parallels the grievances of a assembly of guardians of young ones with autism spectrum disorder and attention deficit hyperactivity disorder who sued the producers of Tylenol in recently.

The court dismissed the legal action, declaring studies from the family's specialists was not conclusive.